Hester Biosciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
1,637.10 +15.30 (0.94%)Updated : 11 Nov 2025
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -33.42-30.3038.86116.87
Net Changein Cash -6.72-0.41-11.593.48
Cash Taxes Paid 11.4711.678.1117.11
Net Income/ Starting Line 39.5731.9540.1553.50
Total Cash Dividends Paid -5.17-6.81-8.51-8.51
Changesin Working Capital -1.53-8.04-28.95-55.79
Cashfrom Operating Activities 64.5148.1323.608.81
Cash Interest Paid 13.1314.9412.592.54
Cashfrom Financing Activities -51.72-26.0441.76111.61
Depreciation/ Depletion 16.8017.1720.7016.58
Other Investing Cash Flow Items Total 1.591.740.76-20.88
Capital Expenditures -20.59-24.40-77.76-95.71
period Type ----
Foreign Exchange Effects -0.510.160.05-0.35
Non- Cash Items 9.667.05-8.31-5.48
Financing Cash Flow Items -13.1311.0611.413.65
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -19.00-22.65-77.00-116.59
Issuance( Retirement)of Stock Net --0.00-0.40
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,009.80-75.60 (-6.97%)
1,994.00-126.45 (-5.96%)